Bailey Chism
The City Journals
Researchers at Intermountain Health have been awarded a $356,000 grant from Merck, a global science and technology company that develops medicines, vaccines and other health solutions, to fight antibiotic resistance and overuse in urgent and outpatient care settings to make sure patients get the best possible treatment for their illnesses. The grant will kick off the Intermountain ReSCORE-UC project — a two-year study on behavioral and organizational drivers of antibiotic use in Please log in to see the rest of this story.
